India’s CDSCO grants APAC Biotech license for immuno-oncology drug Apceden

The Central Drugs Standard Control Organization (CDSCO), India's regulatory authority, has granted a commercial license to APAC Biotech for the marketing of Apceden, a Dendritic ... Read More